rofecoxib has been researched along with Venous Thrombosis in 4 studies
Venous Thrombosis: The formation or presence of a blood clot (THROMBUS) within a vein.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The potential prothrombotic effect of the cyclooxygenase-2 (COX-2) inhibitor Rofecoxib (Vioxx) was investigated using murine thrombosis models." | 7.74 | Prothrombotic effect of Rofecoxib in a murine venous thrombosis model. ( Gallacher, DJ; Hoylaerts, MF; Lijnen, HR; Lu, HR; Nagai, N, 2008) |
| "The potential prothrombotic effect of the cyclooxygenase-2 (COX-2) inhibitor Rofecoxib (Vioxx) was investigated using murine thrombosis models." | 3.74 | Prothrombotic effect of Rofecoxib in a murine venous thrombosis model. ( Gallacher, DJ; Hoylaerts, MF; Lijnen, HR; Lu, HR; Nagai, N, 2008) |
| "MNA, however, did not affect venous thrombosis." | 1.34 | 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway. ( Adamus, J; Bartus, M; Buczko, W; Chlopicki, S; Gebicki, J; Lomnicka, M; Mogielnicki, A; Swies, J, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagai, N | 1 |
| Hoylaerts, MF | 1 |
| Gallacher, DJ | 1 |
| Lu, HR | 1 |
| Lijnen, HR | 1 |
| Chlopicki, S | 1 |
| Swies, J | 1 |
| Mogielnicki, A | 1 |
| Buczko, W | 1 |
| Bartus, M | 1 |
| Lomnicka, M | 1 |
| Adamus, J | 1 |
| Gebicki, J | 1 |
| Cleland, LG | 1 |
| James, MJ | 1 |
| Stamp, LK | 1 |
| Penglis, PS | 1 |
| Fenn, CG | 1 |
1 review available for rofecoxib and Venous Thrombosis
| Article | Year |
|---|---|
COX-2 inhibition and thrombotic tendency: a need for surveillance.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Celecoxib; Cyclooxygenase I | 2001 |
3 other studies available for rofecoxib and Venous Thrombosis
| Article | Year |
|---|---|
Prothrombotic effect of Rofecoxib in a murine venous thrombosis model.
Topics: Animals; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Femoral Artery; Jugular Veins; Lactone | 2008 |
1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway.
Topics: Animals; Aorta; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Epoprostenol; Fibrinolytic Agents; Hy | 2007 |
COX-2 inhibition and thrombotic tendency.
Topics: Celecoxib; Cyclooxygenase Inhibitors; Humans; Lactones; Myocardial Infarction; Pyrazoles; Sulfonamid | 2002 |